The Glucocorticoid Receptor: Molecular Mechanism and New Therapeutic Opportunities
Current Drug Target -Inflammation & Allergy · 2002
DOI: 10.2174/1568010023344751 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Drug Target -Inflammation & Allergy, 2002. Verfasst von Leonard Buckbinder und 1 weiteren Autor:innen. Beteiligte Einrichtung: Pfizer Inc., Global Research and Development, Groton Laboratories, Eastern Point Road, Groton, CT 06340, USA. buckbinder@groton.pfizer.com. Die Arbeit wurde bisher 32-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Pfizer Inc., Global Research and Development, Groton Laboratories, Eastern Point Road, Groton, CT 06340, USA. buckbinder@groton.pfizer.com
Zitieren
APA
Buckbinder, L., & Robinson, R. P. (2002). The Glucocorticoid Receptor: Molecular Mechanism and New Therapeutic Opportunities. Current Drug Target -Inflammation & Allergy. https://doi.org/10.2174/1568010023344751
Vancouver
Buckbinder L, Robinson RP. The Glucocorticoid Receptor: Molecular Mechanism and New Therapeutic Opportunities. Current Drug Target -Inflammation & Allergy. 2002. doi:10.2174/1568010023344751
BibTeX
@article{Buckbinder2002,
author = {Buckbinder, Leonard and Robinson, Ralph P},
title = {The Glucocorticoid Receptor: Molecular Mechanism and New Therapeutic Opportunities},
journal = {Current Drug Target -Inflammation & Allergy},
year = {2002},
doi = {10.2174/1568010023344751}
}
EUVIMED